Tisotumab Vedotin in Squamous Cell Carcinoma of the Vulva
NCT07672782
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
28
Enrollment
NETWORK
Sponsor class
Conditions
Vulvar Carcinoma
Recurrent or Metastatic Vulvar Cancer
Squamous Cell Carcinoma Vulva
Interventions
DRUG:
Tisotumab Vedotin
Sponsor
GOG Foundation
Collaborators
[object Object]